Competitor Analysis: Bruton’s Tyrosine Kinase (BTK) Inhibitors

  • ID: 2640100
  • Report
  • 13 Pages
  • La Merie Publishing
1 of 4

FEATURED COMPANIES

  • Advinus Therapeutics
  • Aegera Therapeutics
  • Aurigene
  • Celgene
  • Hanmi Pharmaceutical Co
  • Janssen Biotech
  • MORE
Product description

The present Competitive Intelligence report about Bruton’s Tyrosine Kinase (BTK) Inhibitorsprovides a competitor evaluation in the field of small molecule-based inhibitors of Bruton’s Tyrosine Kinase (BTK) for the treatment of B-cell related hematologic malign ancies and autoimmune diseases as of August 2013. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of currently active projects in research and development of small molecule Bruton’s Tyrosine Kinase (BTK) inhibitors in oncology and inflammatory and autoimmune diseases. In addition, the report lists company-specific R&D pipelines of BTK inhibitors. Competitor projects are listed in a tabular format providing information on:

- Drug Codes
- Target / Mechanism of Action
- Class of Compound
- Company
- Product Category
- Indication
- R&D Stage
- additional comments with a hyperlink leading to the source of information

About theCompetitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Advinus Therapeutics
  • Aegera Therapeutics
  • Aurigene
  • Celgene
  • Hanmi Pharmaceutical Co
  • Janssen Biotech
  • MORE
1. Bruton’s Tyrosine Kinase (BTK) Inhibitors BTK Inhibitors in Oncology
BTK Inhibitors in Inflammatory & Autoimmune Diseases

2. Corporate BTK Inhibitor R&D Pipelines
- Advinus Therapeutics
- Aegera Therapeutics
- Aurigene
- Celgene
- Hanmi Pharmaceutical Co
- Janssen Biotech
- Ono Pharmaceutical Co.
- Pharmacyclics
- Tolero Pharmaceuticals
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
- Advinus Therapeutics
- Aegera Therapeutics
- Aurigene
- Celgene
- Hanmi Pharmaceutical Co
- Janssen Biotech
- Ono Pharmaceutical Co.
- Pharmacyclics
- Tolero Pharmaceuticals
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll